Comparison of the anti-dopamine D₂ and anti-serotonin 5-HT(2A) activities of chlorpromazine, bromperidol, haloperidol and second-generation antipsychotics parent compounds and metabolites thereof.

@article{Suzuki2013ComparisonOT,
  title={Comparison of the anti-dopamine D₂ and anti-serotonin 5-HT(2A) activities of chlorpromazine, bromperidol, haloperidol and second-generation antipsychotics parent compounds and metabolites thereof.},
  author={Hidenobu Suzuki and Keishi Gen and Yuichi Inoue},
  journal={Journal of psychopharmacology},
  year={2013},
  volume={27 4},
  pages={
          396-400
        }
}
Second-generation antipsychotics, which have become the standard drug therapies for schizophrenia, are known to have a serotonin 5-HT(2A) receptor blocking effect in addition to a dopamine D₂ receptor blocking effect. However, although chlorpromazine (CPZ) has a 5-HT(2A) receptor blocking effect and has the profile of a second-generation antipsychotic in vitro, it loses this pharmacological profile in vivo. In order to elucidate the differences between the in vivo and in vitro pharmacological… CONTINUE READING
Highly Cited
This paper has 28 citations. REVIEW CITATIONS
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 28 references

Clinical trial of perospirone in Japan

J Ishigooka
Jpn J Clin Psychopharmacol • 2001
View 6 Excerpts
Highly Influenced